FDA appears to soften stance on hydroxychloroquine after Trump says he takes malaria drug

Published on:

The FDA advised consumers against taking hydroxychloroquine for Covid-19 outside a hospital or formal clinical trial setting due to the risk of “serious heart rhythm problems.”

Read more    Source: cnbc.com